Literature DB >> 29624865

Infection-associated vasculitides.

Syed A Haq1, Christian Pagnoux2.   

Abstract

Vasculitides are disorders characterized by inflammation of the vessel walls, often caused by autoimmunity, but sometimes as a result of microbial invasion. Almost all types of microbes including bacteria, viruses, protozoa and fungi have been incriminated in the pathogenesis of vasculitis. Accurate etiological diagnosis is important since immunosuppressive treatment may lead to further deterioration if infection is the cause of vasculitis. Clinical features sometimes provide clues to the etiology. Further evaluation requires a focused and cost-effective plan of laboratory investigation. The investigations aim at establishing the diagnosis of vasculitis and identify the causative organism. An accurate diagnosis of vasculitis optimally requires histological examination and imaging. For infection-associated vasculitis, the identification of the organism requires studies of stained specimens, cultures, and/or detection of antigens and antibodies. Ideally, the treatment involves administration of an appropriate antimicrobial. In non-self-limiting types of vasculitides, glucocorticoids are needed when the symptoms are progressive, with vital organs involvement, and sometimes, when there is no antimicrobial agent of proven efficacy against the incriminated agent. Additional immunosuppressive agents or interventions must be considered when the disease is severe and/or post-infective immune mechanisms are involved in the pathogenesis, e.g., severe HBV- or HCV-associated vasculitides. Available preventative vaccinations are also crucial. The incidence of HBV-associated vasculitides dramatically decreased following HBV vaccination campaigns, and other infection-associated vasculitides may as well in the future.
© 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  infection; vasculitides

Mesh:

Substances:

Year:  2018        PMID: 29624865     DOI: 10.1111/1756-185X.13287

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  9 in total

Review 1.  Aortitis - An Interdisciplinary Challenge.

Authors:  Tetyana Shchetynska-Marinova; Klaus Amendt; Maliha Sadick; Michael Keese; Martin Sigl
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 2.  Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.

Authors:  Thâmara Cristiane Alves Batista Morita; Gabriela Franco S Trés; Roberta Fachini Jardim Criado; Mirian Nacagami Sotto; Paulo Ricardo Criado
Journal:  An Bras Dermatol       Date:  2020-03-26       Impact factor: 1.896

Review 3.  Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature.

Authors:  Cristina Valero; Juan Pablo Baldivieso-Achá; Miren Uriarte; Esther F Vicente-Rabaneda; Santos Castañeda; Rosario García-Vicuña
Journal:  Rheumatol Int       Date:  2022-06-13       Impact factor: 3.580

4.  An interesting case of small vessel pathology following coronavirus infection.

Authors:  Shadi M Ramadan; Eirini V Kasfiki; Ciaran Wp Kelly; Irshad Ali
Journal:  BMJ Case Rep       Date:  2020-09-07

5.  Pulmonary manifestations of systemic vasculitis in childhood.

Authors:  Adam Lawton; Joseph Machta; Thomas Semple; Atul Gupta
Journal:  Breathe (Sheff)       Date:  2020-12

6.  Vasculitis Secondary to Pulmonary Bacterial Infection: A Case Report.

Authors:  Wangji Zhou; Wei Ye; Juhong Shi; Sanxi Ai; Xinlun Tian
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 7.  Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.

Authors:  Fabian Lötscher; Roxana Pop; Pascal Seitz; Mike Recher; Luca Seitz
Journal:  Curr Rheumatol Rep       Date:  2022-08-03       Impact factor: 4.686

8.  Immunoglobulin A vasculitis induced by atypical pneumonia infection with Chlamydophila pneumonia.

Authors:  Seung Ah Kang; Suha Abu Khalaf; Taylor Nelson
Journal:  IDCases       Date:  2022-09-26

Review 9.  Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?

Authors:  Eleftherios Pelechas; Vassiliki Drossou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Mediterr J Rheumatol       Date:  2020-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.